AXIN SEC filings, in plain English
Everything Axiom Intelligence I has filed with the SEC that we hold — 40 filings, newest first, 38 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: This document is a Schedule 13G beneficial ownership report identifying Highbridge Capital Management, LLC as the reporting entity. Regarding redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, the filing introduces no amendments, voting records, or operational updates; it merely registers beneficial ownership without disclosing share counts, transaction history, or capital deployment adjustments. Why it matters: Highbridge Capital Management, LLC makes no assertions concerning customer bases, revenue streams, total addressable markets, corporate strategies, technological assets, partnership agreements, legal disputes, or management personnel. The filing contains no numerical thresholds, ownership percentages, or financial projections, leaving institutional positioning opaque for redemption calculus or sponsor oversight.
What changed: Schedule 13G beneficial ownership report. The filing identifies Barclays PLC as a reporting holder under Schedule 13G. It reports no amendments to redemption deadlines, trust share values, extension elections, merger transaction progress, or sponsor conduct. It contains no disclosures regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: This routine regulatory submission confirms Barclays PLC’s public equity reporting obligation for AXIN but does not modify the SPAC’s June 20, 2027 termination date, the $10.21 trust per share metric, or the mechanical framework governing shareholder redemptions or the pending business combination. Investors tracking AXIN will find no procedural, financial, or operational adjustments from this document.
What changed: A Form 10-Q quarterly report for the period ended June 30, 2026, filed August 13, 2026. Per the filing, the Trust Account balance grew to $207,868,662 ($10.39 per Public Share), up from $204,234,694 ($10.21 per share) at December 31, 2025, driven by $3,633,968 in interest income. Deal progress advanced significantly with the execution of a Business Combination Agreement on May 25, 2026 to merge with Terra Quantum AG, supported by concurrent Sponsor Support and Shareholder Voting, Support and Lock-Up Agreements. Liquidity deteriorated to $289,541 in cash against a $549,718 working capital deficit, prompting Management to determine that substantial doubt exists regarding the Company’s ability to continue as a going concern. The Sponsor provided a new $1,000,000 unsecured promissory note on July 27, 2026 to fund working capital needs. Outside of these financial updates and the pending transaction, no operating revenues have been generated, administrative service fees remain at $10,000 per month, and the mandatory liquidation deadline remains fixed at June 20, 2027. Additionally, Management stated the company is directing its acquisition search toward the European infrastructure industry. Why it matters: The elevated trust value reduces immediate dilution pressure from redemptions but coincides with complex contingent equity structures in the Terra Quantum merger: Swiss HoldCo shareholders receive up to 50,000,000 earnout shares and management receives up to 25,000,000 earnout shares, each tri-lingually vesting only if the surviving entity’s stock sustains 30-day VWAPs of $12.50, $15.00, or $17.50 over an eight-year window. The acute working capital shortfall relative to execution costs necessitates continued Sponsor funding and elevates liquidation risk if combination efforts fail before the June 20, 2027 deadline. These dynamics directly dictate potential shareholder redemption payouts, post-transaction ownership dilution, and the timeline for converting public units into tradable ordinary shares.
What changed vs 2026-05-14trust $206.0M → $207.9M +1%mandate language changedtrust account, mandate language, combination deadline +22 moved · 3 with no prior record of ours
- Trust account
- $206.0M$207.9M
- Mandate language
- The Company intends to pursue an initial Business Combinatio…we are focusing our search on targets in the European infras…
- Combination deadline
- 2027-06-20 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $300K · unchanged
SpacBrain reads this as $1,838,193 was added to the trust between the two filings.
The clause “Current Assets 461,054 871,711 Long-term prepaid insurance — 48,783 Investments held in Trust Account 207,868,662 204,234,694 Total Assets $ 208,329,716 $ 205,155,188 Liabilities, Class A Ordinary Shares Subject to Possible Redemption,”…
The clause …“of the Public Shares if the Company is unable to complete the initial Business Combination by June 20, 2027, 24 months from the closing of the Initial Public Offering, or by such earlier liquidation date as the Company’s Board”…
The clause …“all operations except for the purpose of liquidating. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate an initial Business Combination prior to the”…
The clause …“available. Advances from Sponsor Advances from Sponsor represent the amounts owed by the Company to the Sponsor in excess of the $ 300,000 principal amount of the IPO Promissory Note. On August 4, 2025, the Company fully repaid the $”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A routine compliance exhibit: Schedule 13G/A amendment to a Statement of Beneficial Ownership. The filing text identifies only the reporting persons, Glazer Capital, LLC and Paul J. Glazer, and contains no operative clauses, share tallies, or acquisition timelines. Accordingly, the document reports no modifications to redemption windows, trust account valuations, extension voting mechanics, merger execution status, or sponsor governance. Why it matters: Attributed entirely to the SEC submission header, this document serves as a standardized transparency instrument for stakeholders maintaining beneficial ownership exceeding five percent of the registered equity class. It contains no assertions regarding commercial clients, financial performance, sector sizing, strategic initiatives, engineering capabilities, alliance structures, judicial proceedings, or leadership transitions. Because the exhibit lacks quantitative disclosures or narrative commentary, it does not impact investor calculations regarding liquidation preferences, conversion ratios, or sponsor commitment adherence.
What changed: A Form 8-K current report announcing the execution of a Sponsor Promissory Note dated July 27, 2026, accompanied by the complete legal instrument as Exhibit 10.1. Filed by Axiom Intelligence Acquisition Corp 1 and signed by Chief Executive Officer and Director Douglas Ward, the report discloses a direct financial obligation: a $1,000,000 unsecured working capital loan from sponsor Axiom Intelligence Holdings 1 LLC. According to the note, borrowings require minimum drawdown requests of $10,000 and must be funded within five business days. The facility bears zero percent interest and matures upon the earlier of a completed business combination or company liquidation. At the sponsor’s sole option, unpaid principal converts into units at $10.00 per unit, with each unit comprising one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share upon IPO consummation. Section 12 explicitly waives the sponsor’s claims against the trust account. The filing notes registration rights referencing an agreement dated June 17, 2025, granting up to three demand registrations. No amendments to the June 20, 2027 redemption deadline or the $10.21 trust-per-share balance were reported. Why it matters: The filing establishes a capped, interest-free sponsor debt line that can be converted into equity at a fixed $10.00 unit ratio, creating potential dilution pathways without requiring additional public capital calls. The explicit trust account waiver prevents sponsor working capital shortfalls from encroaching on shareholder trust proceeds, preserving the existing $10.21 per-share valuation framework. Because the document contains no target-specific updates, merger agreement modifications, or operational disclosures, the acquisition phase and liquidity mechanics remain governed by prior filings.
What changed: SEC Form 425 submitting an English-translated podcast interview featuring Terra Quantum AG Chief Executive Officer Markus Pflitsch, filed pursuant to Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 in connection with the pending business combination between Terra Quantum AG and Axiom Intelligence Acquisition Corp 1. This filing does not amend the SPAC redemption mechanics, the per-share trust value of $10.21, or the liquidation deadline of June 20, 2027. It reports no change to the sponsor relationship, redemption thresholds, or extension provisions. Deal progress remains directed toward a second half of 2026 Nasdaq listing, consistent with the May 29, 2026 Form 8-K announcement. The filing instead introduces newly published operational, strategic, and commercial disclosures from the target company’s leadership. Why it matters: Shareholders weighing redemption decisions against the $10.21 trust value and June 20, 2027 deadline receive substantive forward-looking content from CEO Markus Pflitsch alongside explicit transaction risks. Attributed claims include a target valuation of approximately US$3.5 billion, deployment of quantum computing, quantum AI, quantum cybersecurity, and a proprietary encrypted messaging platform named Whisper, and active commercial engagement with the U.S. government and U.S. Air Force. Pflitsch states that current U.S. directives require roughly 250,000 critical infrastructure operators to adopt quantum-resistant encryption within the next few years, while U.S. government agencies he cites estimate Q-Day (when quantum systems can break public-key cryptography) around 2030, with one study suggesting 2029, creating a three or four year preparation window. He founded Terra Quantum in 2018 after nearly twenty years in corporate finance and banking, is fifty-five years old, and sets a corporate policy declining offensive warfare contracts under a “Quantum for Good” framework. The filing simultaneously catalogs standard deal hazards: potential SEC objections to the Form F-4 registration statement, failure to obtain stockholder approval, inability to meet Nasdaq listing standards, execution risk on projected financial information, commercialization uncertainty, and intellectual property protection challenges. For redemption tracking, the unchanged timeline and trust amount keep the opt-out window active through June 20, 2027, but the heavy dependence on unproven quantum hardware scaling, government procurement pacing, and regulatory clearance underscores the speculative path to realizing the stated valuation before trust expiration.
What changed: Form 425 – Prospectuses and Communications filed pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, submitted to place a published, English-translated Forbes Switzerland media interview on the record. No amendments to redemption procedures, trust/share value, extension triggers, or the June 20, 2027 deadline are reported. Deal progress statements reiterate a proposed business combination valued at approximately US$3.5 billion (CHF 2.8 billion) with expected Nasdaq listing under ticker TQ if closing occurs during the second half of 2026. Capital proceeds are capped at up to US$190 million, explicitly scaled down by the volume of Axiom shareholder redemptions before closing. Sponsor conduct is not addressed. Substance from the filing includes: Terra Quantum founder and CEO Markus Pflitsch claims the company employs more than 200 people (over 70 percent research engineers, more than 35 percent holding doctoral degrees), has raised more than US$100 million historically, operates across seven global locations, and holds more than 100 patents; he further states the firm does not publicly disclose current revenue figures. Pflitsch attributes customer engagements to the U.S. Air Force, Volkswagen, HSBC, Evonik, and Siemens, and asserts the U.S. government was the first sovereign entity to award Terra Quantum a contract. Market sizing and industry data cited include: McKinsey projects the global quantum industry could generate between US$1.3 trillion and US$2.7 trillion in economic value by 2035, identifying chemicals, advanced materials, energy, financial services, logistics, and pharmaceuticals as highest-potential sectors; the QED-C State of Quantum 2026 Report estimates the current market at approximately US$1.9 billion (around US$1.4 billion from quantum computing and another US$470 million from quantum sensing), tracks nearly 70,000 active quantum patents expanding at an average rate of approximately 20 percent annually, records US$12.7 billion in governmental quantum funding announcements in 2025 (a 310 percent jump), and surveys indicate 11 percent of quantum computing firms reported annual revenues exceeding US$5 million a year earlier versus 19 percent in 2025, with more than half anticipating at least 11 percent revenue growth in 2026. Pflitsch additionally lists IBM, Google, Microsoft, Quantinuum, IonQ, D-Wave, and Rigetti as industry participants competing for capital and talent. Why it matters: The filing leaves the SPAC’s statutory framework untouched—trust remains at $10.21 per share, the redemption window operates as previously set, and the liquidation deadline stays at June 20, 2027—but it delivers actionable target-level disclosure ahead of the definitive proxy statement/prospectus. The conditional financing ceiling (up to US$190 million net of redemptions) creates a direct feedback loop: heavier redemption expectations compress the cash runway earmarked for R&D acceleration, global sales expansion, and strategic acquisitions, thereby increasing execution pressure on the commercialization milestones Pflitsch emphasizes. Attributed claims about headcount composition, patent density, geographic footprint, and named enterprise clients provide baseline verification points for investors weighing the stated US$3.5 billion valuation against independent benchmarks like the McKinsey and QED-C market projections. Because the capital raise scales inversely with shareholder exit behavior, tracking pre-close subscription vs. redemption trends is critical; this transcript supplies neither mechanical updates nor extension signals, making the upcoming proxy date and corresponding prospectus the next definitive inflection point for trust preservation and closing probability.
What changed: SEC Form 425 filing containing a published ntv television interview transcript and standard Rule 14a-12 prospectus communication boilerplate submitted in connection with the proposed business combination between Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG. The filing imposes no adjustments to the redemption deadline (2027-06-20), the per-share trust value ($10.21), extension provisions, or sponsor governance. It solely routes a pre-existing media interview into the SEC filing system alongside mandatory solicitation disclaimers and recitations of outstanding closing conditions tied to the existing Business Combination Agreement. Deal mechanics remain unchanged: consummation still requires stockholder approval, SEC clearance of the Form F-4 registration statement, verification that the combined entity meets Nasdaq listing standards, and confirmation that no termination events have occurred under the merger agreement. Why it matters: Though procedurally routine for the SPAC timeline, the attached transcript establishes the public investment thesis Terra Quantum executives intend to advance ahead of an expected Nasdaq debut in the second half of the year. In the transcript, Markus Pflitsch stated that quantum computing will become critical for operating systems and algorithmic control of coordinated robot fleets once conventional AI reaches analytical limits, and he characterized the convergence of AI and quantum technologies as an imminent innovation wave. He asserted that Europe has already lost the classical AI race—citing U.S. dominance in user interfaces and foundational algorithms—and pointed to a visible funding gap reflected in valuation levels and market multiples as the reason Terra Quantum selected a U.S. exchange over German venues. Company disclosures in the same filing warn that success depends on technological feasibility, customer adoption, intellectual property retention, commercialization of quantum security and AI-driven optimization solutions, and sustained reliance on scientific talent and third-party infrastructure. Sponsor leadership remains identified as Richard Dodd (Executive Chairman) and Doug Ward (Chief Executive Officer), with no changes to compensation, conduct, or fiduciary obligations noted.
What changed: A Rule 425 prospectus communication and forward-looking statements filing reproduced by Axiom Intelligence Acquisition Corp 1, containing a LinkedIn post excerpt and an ntv Nachrichten interview summary regarding the proposed business combination with Terra Quantum AG, alongside standard securities law disclaimers, risk factors, and solicitation participant disclosures. The filing updates no mechanics. It does not modify the redemption deadline, alter the trust account status or per-share value, propose an extension, renegotiate deal terms, or reflect any sponsor conduct changes. It is a static informational submission filed solely to satisfy post-announcement communication requirements under the Securities Act of 1933. Why it matters: The filing substantively circulates the target’s stated metrics and strategic rationale ahead of the definitive proxy statement/prospectus. A LinkedIn post attached to the communication cites a '$3.5 billion dollar valuation' for Terra Quantum AG. In a summarized conversation with ntv Nachrichten, Markus Pflitsch attributes the shift toward a Nasdaq listing to 'more capital,' 'higher valuations,' and 'greater openness to innovation.' The filing’s forward-looking statements section explicitly flags investor risks surrounding Terra Quantum’s ability to commercialize 'quantum computing, quantum security, and AI-driven optimization solutions' amid emerging market adoption and technological feasibility uncertainties. Management identification is limited to Richard Dodd (Executive Chairman) and Doug Ward (Chief Executive Officer). For redemption-track investors, the primary takeaway is that the target’s U.S.-centric capitalization narrative is being actively promoted while the regulatory review clock continues uninterrupted.
What changed: This filing is a Form 425 written communication containing a Form 8-K current report and an attached investor presentation dated June 9, 2026, filed to authorize use of preliminary marketing materials for the proposed business combination between Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG. No adjustments to redemption terms, trust account status, or expiration deadline are reported. The filing confirms the Business Combination Agreement executed on May 25, 2026, remains pending shareholder approval via a forthcoming proxy statement/prospectus. Forward-looking statements in the disclosure explicitly warn that if a significant number of Axiom’s ordinary shares are elected to be redeemed, it will reduce the capital available to the post-combination company following the Business Combination and highly concentrate remaining share ownership. Pro forma financial assumptions presented by management indicate a requirement to raise $100M from a combination of PIPE and SPAC cash in trust, with $85M assumed to flow to the balance sheet after $15M in illustrative transaction expenses. Why it matters: Management attributes a $1.3Tn 2035 value creation opportunity in quantum computing to the broader sector, citing BCG and McKinsey research, and delineates addressable markets including Financial Services at $70B-$135B, Medicine & Chemicals at $60B-$130B, Aerospace & Defense at $30B-$70B, Clean Energy at $10B-$30B, Next Gen Batteries at $20B-$40B, Ad Optimization at $50B-$100B, Network Optimization at $50B-$100B, and Automotive at up to $10B. The company claims its proprietary, software-first quantum platform delivers >15x faster optimization, >200x improvement in simulation efficiency, and ~30% faster machine learning, attributing those performance metrics to external studies by Perelshtein et al. (2022) and Aliev et al. (2023). Commercial traction is claimed with enterprise customers including Thales, Uniper, Honda, Volkswagen Group, the U.S. Air Force, and Melita. An illustrative transaction model projects a $3.5B valuation for Terra Quantum and ~$3.6B pro forma enterprise value, implying roughly 95.5% ownership for existing Terra Quantum shareholders and ~2.7% for SPAC/PIPE investors. Public comparable companies reportedly averaged a ~$10.7B enterprise value as of 6/4/2026 per FactSet data cited in the deck. Risk factors highlight early-stage technology commercialization uncertainty, rapid industry evolution, dependence on key scientific personnel (Markus Pflitsch, Dr. Eike Marx, Dr. Florian Neukart), channel partner reliance, and the explicit impact of share redemptions on post-deal capital availability and float concentration.
What changed: Form 8-K (Regulation FD Disclosure) filing that furnishes Exhibit 99.1, a confidential investor presentation promoted in connection with the proposed business combination between Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG. This submission advances the merger timeline by delivering promotional materials to the SEC ahead of the forthcoming proxy statement/prospectus and shareholder vote. It does not amend the existing redemption deadline of June 20, 2027, nor does it introduce new trust account mechanics or extensions relative to the stated $10.21 per-share trust value. Why it matters: The presentation supplies the preliminary financial architecture and commercial thesis driving the deal. According to management and the attached deck, Terra Quantum claims a $1.3 trillion 2035 value creation opportunity sourced from BCG and McKinsey reports, segmented into Addressable Markets citing Financial Services at $70B-$135B, Medicine/Chemicals at $60B-$130B, Aerospace Defense at $30B-$70B, and several other verticals ranging up to $100B. The Company attributes performance differentials to peer-reviewed studies (Perelshtein et al., Aliev et al.), claiming its QKD network operates >10,000x faster than comparators, optimization runs >15x faster/more accurately, and simulation efficiency improves up to >200x. Management lists enterprise deployments and pilots with Thales, Uniper, Honda, Volkswagen Group, the U.S. Air Force, and Melita. Structurally, the deck projects a $3.5 billion base valuation for Terra Quantum, implying ~$3.6 billion pro-forma enterprise value. It assumes a $100 million PIPE and trust cash raise, a $10.00 assumed public share price, and 366.7 million total shares outstanding. The proposed cap table shows Terra Quantum shareholders rolling over 100% of their equity for ~95.5% ownership, SPAC/PIPE investors taking 2.7%, and the sponsor retaining 1.8%. Critically, the filing's risk factors explicitly warn that substantial shareholder redemptions will drain capital available to the surviving entity and highly concentrate post-combination ownership, while also noting that some Axiom officers and directors may face conflicts of interest in approving the deal.
What changed: Form 8-K filed pursuant to Rule 425 under the Securities Act disclosing a Business Combination Agreement dated May 25, 2026, between Axiom Intelligence Acquisition Corp 1 ('SPAC') and Terra Quantum AG ('Company'), together with an attached Sponsor Support Agreement and a form Shareholder Voting, Support and Lock-Up Agreement. The filing establishes definitive terms for a proposed business combination targeting a company the parties describe as developing, commercializing, and scaling 'quantum computing, quantum security and AI-driven optimization solutions' (attributed to SPAC and the Company in the Forward-Looking Statements section). Mechanics updated include: a Trust Account balance of $206,030,469; a valuation construct defining 'Price per Share' as the quotient of $3,500,000,000 divided by fully diluted outstanding Swiss HoldCo Shares; a mandatory effort obligation to secure at least $30,000,000 in PIPE investments; and a 75,000,000-share earnout pool (50,000,000 Swiss HoldCo Earnout Shares and 25,000,000 Management Earnout Shares) issuable in three tranches triggered by a 30-day VWAP of $12.50, $15.00, and $17.50 over an eight-year period. The Sponsor (Axiom Intelligence Holdings 1, LLC) irrevocably waives anti-dilution adjustments, vows not to redeem, pledges to vote in favor, and accepts a 180-day lock-up subject to a $12.00 VWAP breakout. SPAC Chief Executive Officer Douglas Ward personally guarantees a $15,000,000 diligence termination fee payable to the Company if SPAC elects to walk away during the diligence window. Why it matters: The $206,030,469 trust balance anchors the maximum redemption exposure available to public shareholders prior to closing, directly impacting net proceeds available to fund operations post-deal. The Sponsor’s explicit surrender of Article 17.4 anti-dilution conversion ratios eliminates potential future dilution pathways outside the approved transaction structure. The layered earnout mechanism ties substantial management and shareholder compensation exclusively to sustained market performance thresholds ($12.50, $15.00, $17.50), signaling confidence in the target’s quantum computing and AI-driven optimization roadmap while transferring near-term execution risk to founders rather than public capital. The CEO’s personal $15,000,000 liability for unilateral diligence termination creates asymmetric contractual risk that discourages frivolous deal abandonment. Additionally, the target’s operational focus relies heavily on intellectual property assets, generative AI compliance frameworks, and proprietary software, with the Company representing that no material litigation, sanctions violations, or anticorruption breaches exist, though risks around market adoption, technological feasibility, and regulatory clearances remain material uncertainties per the Company’s forward-looking disclosures.
What changed: An 8-K Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 disclosing the entry into a Business Combination Agreement, a Sponsor Support Agreement, and a form of Shareholder Voting, Support and Lock-Up Agreement. As drafted in the attached agreements, the transaction mechanics stipulate that the Sponsor Support Agreement binds the Sponsor—which Schedule A confirms holds 400,000 SPAC Class A Ordinary Shares, 6,666,667 SPAC Class B Ordinary Shares, and 400,000 SPAC Rights—to vote in favor of the merger and waive its right to redeem any Subject Shares. Sponsor shares are locked up for 180 days or until the PubCo Ordinary Shares’ 30-day VWAP reaches $12.00 for 20 trading days within a 30-trading day period. Section 4.13 of the Business Combination Agreement represents the Trust Account contains at least $206,030,469. The agreement may be terminated one year after the initial Proxy/Registration Statement filing, and Section 11.3 triggers a $15,000,000 Diligence Termination Fee payable by Douglas Ward if SPAC exercises sole discretion to abandon the deal during the Diligence Review Period. Regarding substantive business operations, Section 3.14 details the Company’s intellectual property portfolio, stating ownership of Owned IP including Patents, Trademarks, copyrights, mask works, and Trade Secrets essential to conducting business in quantum computing, quantum security, and AI-driven optimization solutions. Section 9.5 mandates reasonable best efforts to secure at least $30,000,000 in committed PIPE investments, while Section 2.7 structures an earnout of up to 50,000,000 Swiss HoldCo Earnout Shares and 25,000,000 Management Earnout Shares conditional on 30-day VWAP thresholds of $12.50, $15.00, and $17.50 over eight years. The proposed Price per Share is defined as the quotient of $3,500,000,000 divided by fully diluted Swiss HoldCo Shares. Post-closing governance establishes a seven-member board (five designated by the Company, two by SPAC) and a PubCo Incentive Equity Plan with a 10% initial fully diluted reserve plus a 5% annual evergreen provision. Why it matters: These definitive terms materially reduce execution risk by contractually forbidding Sponsor redemptions and front-loading a $15,000,000 diligence termination fee, which discourages opportunistic SPAC withdrawals during due diligence. The structured earnout and $12.00 sponsor liquidity trigger create measurable performance milestones that align long-term shareholder returns with post-merger trading volume. The explicit $3,500,000,000 valuation denominator anchors expectations for public float dilution, while the mandatory $30,000,000 PIPE threshold ensures adequate post-closing operating capital, directly impacting the sustainability of the combined entity's quantum computing and AI-driven optimization strategy.
What changed: Form 8-K filing under Rule 425 submitting a Regulation FD disclosure and an attached press release announcing a definitive Business Combination Agreement. Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG announced the execution of a definitive Business Combination Agreement dated May 25, 2026, moving the transaction from prior negotiations to a binding merger pathway. According to the attached press release, the deal assigns Terra Quantum an equity value of approximately $3.5 billion, representing an increase from a previously announced non-binding letter of intent, and cites a pro forma enterprise value of approximately $3.6 billion assuming no redemptions by Axiom’s public stockholders. Ownership is projected to allocate approximately 92% to existing Terra Quantum shareholders—who would roll 100% of their equity into the combined entity—and approximately 8% to Axiom’s public stockholders and sponsor, again assuming zero redemptions. The filing states the trust account funds available at the time of the IPO are expected to deliver up to approximately $190 million of gross proceeds to the combined company, excluding transaction costs and predicated on no redemptions. The structural plan identifies a Swiss public limited company as PubCo and a Cayman Islands exempted company as Merger Sub, with a closing target in the second half of 2026 subject to customary conditions. This document does not amend the redemption deadline, extend the trust period, or disclose modifications to sponsor conduct; standard prerequisites including Axiom shareholder approval, SEC registration statement effectiveness, and Nasdaq listing approval remain outstanding. Why it matters: The announcement materially alters the redemption calculus and capital structure assumptions for Axiom shareholders. Because the $190 million trust-derived liquidity baseline and the 92% versus 8% ownership split are explicitly conditioned on Axiom public stockholders making no redemptions, investors tracking liquidation timelines and trust distributions must model redemption-heavy scenarios against these disclosed figures. The press release attributes Terra Quantum’s technology roadmap to founder and CEO Markus Pflitsch, who states the company offers a unified stack combining quantum computing, quantum-inspired optimization, artificial intelligence, and quantum cybersecurity designed for enterprise deployment rather than pure hardware development. Pflitsch and CTO Dr. Florian Neukart attribute commercial traction to the firm, noting ongoing revenue generation across financial services, manufacturing, pharmaceuticals, logistics, energy, government, and defense sectors. Terra Quantum management characterizes the addressable market as projecting substantial growth over the coming decades as enterprises adopt quantum solutions for optimization, simulation, machine learning, and cybersecurity applications. Axiom CEO Doug Ward attributes his endorsement to Terra Quantum’s combination of scientific excellence, proprietary technology, enterprise adoption, and deep-tech scaling track record. Dr. Eike Marx is named as the continuing CFO and Chief Strategic Officer. The press release confirms the combined entity will trade on Nasdaq under the ticker symbol “TQ.” Until the Form F-4 proxy statement/prospectus is filed, exact redemption mechanics, potential PIPE sizing, and final trust distribution per share remain unconfirmed, but this filing establishes the definitive valuation anchor, pro forma ownership matrix, and near-term closing target driving investor decisioning ahead of the June 2027 deadline.
What changed: Form 8-K filing (Item 7.01 Regulation FD Disclosure) accompanied by Exhibit 99.1, a press release officially announcing a definitive Business Combination Agreement between Axiom Intelligence Acquisition Corp 1 (AXIN) and Terra Quantum AG. This filing formalizes the merger announcement, establishing an equity valuation of approximately $3.5 billion for Terra Quantum and an implied pro forma enterprise value of approximately $3.6 billion, assuming no redemptions. Pro forma ownership assumes Terra Quantum shareholders roll 100% of their equity into the transaction, resulting in approximately 92% ownership of the combined company, while Axiom’s public stockholders and sponsor are expected to own approximately 8%. The press release notes the SPAC trust account could deliver up to approximately $190 million in gross proceeds assuming no redemptions, with potential PIPE financing. Closing targets the second half of 2026, contingent on Axiom shareholder approval, Form F-4 registration statement effectiveness, customary conditions, regulatory approvals, and Nasdaq listing. Combined company leadership will comprise Founder & CEO Markus Pflitsch, CFO and Chief Strategic Officer Dr. Eike Marx, and CTO Dr. Florian Neukart. The combined company's Nasdaq ticker symbol is expected to be “TQ”. Why it matters: For redemption and trust tracking, the document does not amend the 2027-06-20 deadline or alter the stated per-share trust value, but it explicitly ties the $190 million trust-derived liquidity assumption to a zero-redemption scenario. The high private-holder rollover percentage signals substantial dilution for remaining public shares absent redemptions or external financing. This 8-K initiates the proxy/prospectus filing cycle, which will lock formal voting records, tender windows, and precise trust payout mechanics. Regarding business fundamentals, the attached press release attributes claims that Terra Quantum currently serves enterprise customers across financial services, manufacturing, pharmaceuticals, logistics, energy, government, and defense sectors. The company describes its technology stack as integrating proprietary quantum algorithms, quantum security solutions, hybrid quantum-classical computing, and AI-driven optimization into unified software platforms. While the filing characterizes the global quantum computing market as having a massive opportunity projected to grow substantially over coming decades, it provides no specific revenue figures or dollar-valued market size. Legal advisors are identified as Ellenoff Grossman & Schole LLP and Bratschi for Axiom, and Heussen Rechtsanwaltsgesellschaft mbH, Kellerhals Carrard, Winston & Strawn LLP, and Niedermann Rechtsanwälte for Terra Quantum. No active litigation is disclosed, though standard forward-looking statements caution about potential post-announcement legal proceedings and regulatory delays.
What changed: Form 10-Q Quarterly Report for the quarterly period ended March 31, 2026. This document is a Form 10-Q Quarterly Report for the quarterly period ended March 31, 2026. Regarding deal mechanics, Management reports the trust account valuation stands at $10.30 per public share as of March 31, 2026, with a fixed liquidation deadline of June 20, 2027. Deal progress remains unadvanced, as Management confirmed the company has not entered into a definitive agreement with any specific business combination target despite targeting opportunities in the European infrastructure industry. Sponsor conduct disclosures include accrued $30,000 in administrative service fees for the quarter, execution of a Letter Agreement waiving redemption rights, and grant of 150,000 founder shares to independent directors. Reporting other substance, Management discloses generating $1,795,775 in non-operating interest income offset by $274,966 in general and administrative expenses, yielding a reported net income of $1,520,809. Corporate cash declined to $545,146. Management asserts no material litigation is pending and certifying officers concluded internal controls remain effective. However, Management flagged substantial doubt regarding the company’s ability to continue as a going concern due to expected sustained operating costs and potential financing gaps. Why it matters: The $10.30 per-share trust valuation directly dictates the maximum cash payout available to redeeming shareholders and influences redemption calculus as the hard June 20, 2027 deadline approaches. Management’s explicit confirmation of an unresolved acquisition hunt narrows the operational runway and explains the documented going concern warning triggered by the projected depletion of the $545,146 cash reserve against the unreduced $274,966 quarterly burn rate masked by temporary interest offsets. The recorded sponsor fee accruals and equity grants illustrate the financial incentives and voting alignments that will govern sponsor behavior during the final push for a European infrastructure target, while Management’s denial of pending litigation and affirmation of control effectiveness removes immediate legal or governance roadblocks from the remaining acquisition timeline.
What changed vs 2025-11-13trust $202.3M → $206.0M +2%going concern APPEAREDtrust account, going-concern doubt, combination deadline +22 moved · 3 with no prior record of ours
- Trust account
- $202.3M$206.0M
- Going-concern doubt
- not statedstated
- Combination deadline
- 2027-06-20 · unchanged
- Sponsor loans outstanding
- $300K · unchanged
- Mandate language
- The Company intends to pursue an initial Business Combinatio… · unchanged
SpacBrain reads this as $3,764,616 was added to the trust between the two filings.
The clause …“Assets 716,765 871,711 Long-term prepaid insurance 22,332 48,783 Investments held in Trust Account 206,030,469 204,234,694 Total Assets $ 206,769,566 $ 205,155,188 Liabilities, Class A Ordinary Shares Subject to Possible Redemption,”…
SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.
The clause …“all operations except for the purpose of liquidating. These conditions raise substantial doubt about the Company s ability to continue as a going concern. Management plans to consummate an initial Business Combination prior to the”…
The clause …“of the Public Shares if the Company is unable to complete the initial Business Combination by June 20, 2027, 24 months from the closing of the Initial Public Offering, or by such earlier liquidation date as the Company s board”…
The clause …“available. Advances from Sponsor Advances from Sponsor represent the amounts owed by the Company to the Sponsor in excess of the $ 300,000 principal amount of the IPO Promissory Note. On August 4, 2025, the Company fully repaid the $”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 10-K annual report for Axiom Intelligence Acquisition Corp 1 for the fiscal year ended December 31, 2025. The filing confirms the company’s trust account balance stands at $204,234,694, translating to an approximate redemption price of $10.21 per Public Share as of December 31, 2025. The combination period remains set to end on June 20, 2027. No definitive business combination agreement has been executed, as the management team continues searching for targets primarily within the European infrastructure sector. Additionally, the company detailed its post-IPO capital structure, noting $6,000,000 raised in a concurrent private placement with sponsor Axiom Intelligence Holdings 1, LLC, underwriters CCM and Seaport, and working capital outside the trust of approximately $736,280. Why it matters: For investors tracking SPAC timelines and capital, this report verifies the exact per-share trust valuation ahead of potential market fluctuations or extension votes, while confirming the extended timeline through mid-2027 provides ample runway to secure a European infrastructure target. The disclosure of limited cash reserves outside the trust (~$736,280) alongside administrative service agreements ($10,000/month to the Sponsor) highlights the operational funding constraints management must navigate before closing a deal. Furthermore, the adoption of executive compensation clawback and insider trading compliance policies establishes the corporate governance framework expected during the search phase.
What changed: This document IS a Schedule 13G/A amendment beneficial ownership report filed by Barclays PLC. Barclays PLC submitted this Schedule 13G/A to report its beneficial ownership position in AXIN. The submitted excerpt contains no numerical share quantities, percentage thresholds, redemption requests, trust account adjustments, deadline extensions, or merger execution updates. All reported information is limited to Barclays PLC’s identification as the filing entity and the routine regulatory nature of the submission. Why it matters: Because this filing is a routine compliance exhibit rather than a merger agreement, resignation, interview transcript, investor presentation, or lawsuit, it does not mechanically affect the $10.21 trust/share amount or the 2027-06-20 redemption deadline. The text attributes no customer claims, revenue figures, market size estimates, strategic pivots, technology developments, partnership announcements, litigation defenses, or personnel changes to Barclays PLC or AXIN. Consequently, it does not influence shareholder redemption decisions, sponsor conduct assessments, or deal progress tracking. Materiality would require subsequent disclosures that quantify position shifts or address business combination milestones.
What changed: Routine compliance exhibit (Quarterly Report on Form 10-Q for Axiom Intelligence Acquisition Corp 1 for the period ended September 30, 2025). Per the filing, the Trust Account balance grew to $202,265,853, equating to $10.11 per Public Share following $2,084,399 in accrued interest for the quarter. On August 4, 2025, the Sponsor cleared a $2,000,000 share subscription receivable by injecting $997,258 into operating funds and retiring $300,000 in IPO Promissory Notes plus $702,742 in direct sponsor advances. Deal progress remains stalled with no definitive agreements signed, no target identified, and no timeline extensions filed; the mandatory redemption window stays locked at June 20, 2027. Why it matters: Standard treasury yields incrementally buffer public shareholders’ redemption floor against ongoing administrative drains while preserving the $202,265,853 principal cushion. The Sponsor’s working capital settlement removes operational friction without encroaching on protected trust assets or triggering early liquidation conditions. With the June 20, 2027 expiration unmoved and zero movement toward a European infrastructure target, shareholder optionality and default liquidation parameters remain entirely unchanged.
What changed vs 2025-08-12trust $200.2M → $202.3M +1%deadline 2028-06-17 → 2027-06-20trust account, combination deadline, sponsor loans outstanding +22 moved · 3 with no prior record of ours
- Trust account
- $200.2M$202.3M
- Combination deadline
- 2028-06-172027-06-20
- Sponsor loans outstanding
- $300K · unchanged
- Mandate language
- The Company intends to pursue an initial Business Combinatio… · unchanged
- Redeemable shares
- 20.0Mnot matched in this filing
SpacBrain reads this as $2,084,399 was added to the trust between the two filings.
The clause “5 Total Current Assets 1,056,283 Long term prepaid insurance 75,234 Investments held in Trust Account 202,265,853 Total Assets $ 203,397,370 Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders Deficit”…
SpacBrain reads this as 363 days earlier than the previous record.
The clause …“of the Public Shares if the Company is unable to complete the initial Business Combination by June 20, 2027, 24 months from the closing of the Initial Public Offering, or by such earlier liquidation date as the Company s board”…
The clause …“available. Advances from Sponsor Advances from Sponsor represents the amounts owed by the Company to the Sponsor in excess of the $ 300,000 principal amount of the IPO Promissory Note. On August 4, 2025, the Company fully settled the $”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Schedule 13G beneficial ownership report. The filing text exclusively names Barclays PLC as the submitting holder. It contains no language, amendments, or numerical data addressing redemption thresholds, trust value, merger deadlines, shareholder election mechanics, trust account administration, extension voting procedures, or sponsor conduct. Why it matters: Because the excerpt omits all operative clauses, financial schedules, and strategic disclosures, it does not shift baseline assumptions regarding capital allocation, redemption exposure, or acquisition pacing. The submission presents no assertions about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: A routine compliance exhibit — specifically, an SEC Schedule 13G/A amending beneficial ownership disclosure for institutional equity holders. The filing identifies AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC as amended filers reporting equity positions in AXIN. The provided excerpt contains only the form designation and holder names; it omits the exact share quantities, percentage adjustments, acquisition or disposition dates, and investment purpose clauses that would quantify how the holding shifted relative to the most recent prior schedule. Why it matters: Because it is a standard regulatory ownership update, the amendment does not alter the redemption calendar, adjust the per-share trust allocation, trigger an extension provision, advance or delay the announced business combination, or reflect sponsor governance conduct. Large multi-strategy allocators routinely file these amendments for portfolio reconciliation, index inclusion, or internal recordkeeping, which typically signals passive positioning rather than strategic intervention. As no customer attestations, revenue metrics, total addressable market estimates, product roadmaps, technology validations, partnership structures, litigation defenses, or executive commentary appear in the excerpt, the filing introduces no substantive catalysts for redemption calculus, merger milestone tracking, or capital commitment timing. Investors should obtain the full Exhibit 99.1 to confirm the precise delta in reported shares, verify whether the statement classifies the position as passive or active under Section 13(d), and assess whether subsequent transactions could cross or fall below 5% reporting thresholds that would shift voting dynamics ahead of the announced deal closure.
What changed: A Securities and Exchange Commission Schedule 13G – beneficial ownership report, identified by submission index [0001076809-25-000094], listing Glazer Capital, LLC and Paul J. Glazer as the designated reporting holders. The provided filing text discloses only the regulatory form type and the names of the reporting entities. It contains zero share quantities, percentage thresholds, acquisition dates, purchase prices, sources of funds, or purpose statements. Consequently, it delivers no update to merger execution progress, redemption window mechanics, trust account valuation dynamics, extension voting procedures, or sponsor governance conduct. No assertions regarding customer concentrations, revenue trajectories, addressable markets, commercial strategy, technology roadmaps, alliance structures, pending legal proceedings, or executive appointments are present in the excerpt. Why it matters: Because the fragment lacks all numerical holdings, transaction timing, and investment rationale, it does not adjust investor modeling for potential redemptions, alter projected per-share trust distributions, compress or extend the business combination deadline, or reveal sponsor lock-up or commitment changes. Until the full Schedule 13G appendix is filed, analysts cannot verify whether Glazer Capital or Paul J. Glazer have breached or cleared the five percent beneficial ownership trigger, initiated additional open-market accumulations, or coordinated with management on deal support. Based solely on this text, no mechanical or strategic recalibration is required.
What changed: Schedule 13G beneficial ownership report identifying AQR Capital Management, LLC; AQR Capital Management Holdings, LLC; and AQR Arbitrage, LLC as reporting persons. The excerpt lists three AQR-affiliated entities as filers but provides no share quantities, percentages of outstanding shares, acquisition dates, purchase prices, or prior holding comparisons. No statements address redemption thresholds, trust account composition, extension voting, merger proxy timing, target company progress, or sponsor governance or indemnification conduct. Why it matters: Institutional 13G filings often surface when portfolios cross the 5% beneficial ownership threshold, which for SPACs can indicate passive investment or active arbitrage positioning ahead of business combinations or deadline extensions. Because the provided text lacks the total shares beneficially owned, acquisition date, or purpose of the securities, it does not shift the reported $10.21 per-share trust value, alter the 2027-06-20 liquidation deadline, or confirm whether the positions are hedged against redemptions. Tracking these entities in subsequent quarterly reports would be required to determine if capital is deployed ahead of a de-SPAC vote or held through a trust maturity event.
What changed: Form 10-Q Quarterly Report for Axiom Intelligence Acquisition Corp 1 (AXIN), filed August 12, 2025, covering the quarterly period ended June 30, 2025. Per Notes 1 and 10, the Trust Account balance stands at $200,181,454 as of June 30, 2025, reflecting $181,454 in interest earned and accrued. The filing confirms the statutory redemption deadline remains June 20, 2027, per the defined Combination Period, while Management notes Nasdaq rules require completion by June 17, 2028 to avoid trading suspension. Deal progress shows no target selected as of June 30, 2025; the Company states it intends to pursue the European infrastructure industry and records total transaction costs of $12,624,206 ($4,000,000 cash underwriting fee, $8,000,000 Deferred Fee, and $624,206 other offering costs). Regarding sponsor conduct, Notes 5 and 10 disclose that the Sponsor granted 150,000 Founder Shares to independent directors for services, with a total fair value of $236,250 ($1.575 per share), and subsequently on August 4, 2025, settled a $2,000,000 share subscription receivable by depositing $997,258 into the operating account after repaying a $300,000 IPO Promissory Note and $656,101 in advances. The Administrative Services Agreement sets monthly sponsor payments at $10,000, with up to $1,500,000 available in convertible Working Capital Loans. Why it matters: The exact Trust balance of $200,181,454 directly dictates the maximum potential redemption price for Public Shareholders, while the June 17, 2028 Nasdaq deadline establishes the absolute outer boundary for extension mechanisms before mandatory delisting. The explicit lack of a selected acquisition target combined with $12,624,206 in sunk transaction costs underscores that sponsor-funded operational runway—supported by the $10,000/month administrative fees and potential loan conversions—is essential to preserve shareholder value ahead of target identification. The documented settlement of $956,101 in pre-IPO financing obligations by the Sponsor reduces near-term liquidity risk and signals continued financial backing, mitigating short-term liquidation exposure for Public Shareholders.
trust account, combination deadline, sponsor loans outstanding +2nothing moved · 5 with no prior record of ours
- Trust account
- not previously extracted$200.2M
- Combination deadline
- not previously extracted2028-06-17
- Sponsor loans outstanding
- not previously extracted$300K
- Redeemable shares
- not previously extracted20.0M
- Mandate language
- The Company intends to pursue an initial Business Combinatio… · unchanged
The clause “Current Assets 210,132 Long term prepaid insurance 101,685 Cash and investments held in Trust Account 200,181,454 Total Assets $ 200,493,271 Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders Deficit”…
The clause “Articles to extend the date by which we are permitted to consummate our initial Business Combination, we would still need to consummate our initial Business Combination on or prior to June 17, 2028 in order to avoid a suspension of our”…
The clause …“closing of the Initial Public Offering. As of June 30, 2025, the Company had $ 300,000 outstanding under the IPO Promissory Note, which was due on demand. Borrowings under the IPO Promissory Note are no longer available. On August 4,”…
The clause …“500,000,000 shares authorized; 600,000 issued or outstanding (excluding 20,000,000 shares subject to possible redemption) 60 Class B Ordinary Shares, $ 0.0001 par value; 50,000,000 shares authorized; 6,666,667 shares issued and”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 8-K current report accompanied by a press release, serving as a routine listing notice that announces the voluntary separation and decoupling of previously issued Units into distinct, separately traded securities. Per the July 31, 2025 filing, commencing August 1, 2025, holders of Units may elect to separately trade the embedded Class A ordinary shares and Share Rights. The separated Class A ordinary shares will trade on the Nasdaq Global Market under the symbol “AXIN,” the separated rights under “AXINR,” and any intact Units will continue trading under “AXINU.” The press release specifies that Unit holders must have their brokers contact Continental Stock Transfer & Trust Company to execute the separation. This disclosure does not modify the externally tracked redemption deadline of June 20, 2027, nor does it impact the reported trust account balance of $10.21 per share. Why it matters: The mechanical decoupling grants investors independent trading exposure to the equity and rights components ahead of a deSPAC transaction, which is standard administrative procedure but introduces no alterations to the redemption calendar, extension triggers, or sponsor conduct metrics. Regarding substantive corporate developments, the accompanying press release attributes a strategic mandate to management, stating the Company intends to focus its initial search on companies in the European infrastructure industry. The filing contains no information regarding target selection progress, transaction financing, customer pipelines, revenue projections, or pending litigation. Identified leadership includes Executive Chairman Richard Dodd and Chief Executive Officer Douglas Ward. The document further clarifies the original offering structure: each Unit consisted of one Class A ordinary share carrying a par value of $0.0001 and one right entitled to deliver one-tenth (1/10) of one Class A ordinary share upon consummation of an initial business combination.
What changed: This document is a Form 10-Q quarterly report, a routine compliance exhibit disclosing the registrant's post-incorporation financial position, subsequent consummation of its initial public offering and private placement, trust account mechanics, sponsor conduct provisions, and confirmed absence of target discussions or deal progress. Mechanics & Trust/Deadline Terms: The filing states the Company ‘had not selected any specific Business Combination target and... had not... engaged in any substantive discussions’ with any target. Upon IPO closing on June 20, 2025, the Company deposited $200,000,000 into a trust account, initially arranged at $10.00 per Public Share. The document outlines a 24-month Completion Window; if no deal occurs, the Company will redeem Public Shares for a pro-rata trust balance, permitting up to $100,000 in interest to fund dissolution expenses. Sponsor Conduct: The Sponsor pays an aggregate of $10,000 per month for administrative services beginning June 17, 2025, retains 6,708,333 founder shares, and allocated 150,000 founder share membership interests to three independent directors totaling $236,250 ($1.575 per share). A $123,549 promissory note remains outstanding, and a $1,500,000 working capital loan facility remains undrawn. The Sponsor waives redemption and liquidation rights for insiders, accepts liability if third-party claims reduce the trust below $10.00 per Public Share, and agrees to vote all founder shares in favor of a combination. Underwriters secured a 2.00% cash discount ($4,000,000) and retain a 4.00% deferred discount ($8,000,000) payable solely from post-redemption trust balances. Other Substance: The Cayman Islands registrant reports a pre-IPO net loss of $84,438 comprised entirely of general and administrative expenses, holds $7,233 in prepaid expenses and $177,147 in deferred offering costs against liabilities of $115,269 in accrued offering costs and $5,000 in accrued expenses. The filing notes that proceeds in the Trust Account could become subject to creditor claims, which could have priority over the claims of the Company’s public shareholders. Share Rights will expire worthless absent a combination, the entity operates as a single segment, is tax-exempt in the Cayman Islands, and utilizes FDIC-insured bank accounts where deposits occasionally exceed the $250,000 coverage limit. Why it matters: The explicit absence of target engagements confirms the SPAC remains in a pure capital-search phase, tethering public value strictly to the documented trust floor plus accrued interest net of taxes. The sponsor liability provision, insider waiver structures, and rigid 24-month liquidation timeline collectively establish a defined downside ceiling and mandatory exit path for investors. Structural safeguards—such as restricting trust investments to short-term Treasuries or cash to prevent Investment Company Act classification, and clarifying that creditor claims are documented to potentially priority over public shareholder claims—dictate liquidity risk assessment. Furthermore, the forfeiture of 41,666 founder shares following the partial over-allotment exercise and the valuation of director grants at $1.575 per share demonstrate precise equity dilution mechanics and compensation alignment metrics that govern ongoing sponsor conduct and public shareholder protection until a transaction materializes.
What changed: A Joint Filing Agreement (Exhibit 99.1) submitted alongside a Schedule 13D, executed by Axiom Intelligence Holdings 1 LLC, Richard H. Dodd, and Douglas Ward. The filing does not modify the reported trust value ($10.21 per share), the stated redemption deadline (June 20, 2027), or the announced merger status. Instead, the agreement stipulates that the three parties are eligible to file the Schedule 13D jointly for their beneficial ownership of Class A ordinary shares as of June 20, 2025, and contractually assigns each party responsibility for the timeliness, completeness, and accuracy of the information contained in the Schedule 13D. Why it matters: Although the exhibit contains no operational claims, strategic updates, partnership announcements, or personnel changes, it establishes explicit disclosure accountability among the holding company and two named individuals. By mutually representing eligibility and sharing liability for data accuracy, the signatories reduce regulatory ambiguity around their combined equity position. For investors monitoring redemption windows and sponsor conduct, this coordination mechanism signals synchronized oversight of their stake, which can affect voting alignment, secondary liquidity perceptions, and potential trigger calculations near the merger closing, even though it leaves the calendar and per-share trust amount unchanged.
What changed: Form 8-K Current Report and accompanying Exhibit 99.1 (Audited Balance Sheet and accompanying Notes) documenting the consummation of the Company’s initial public offering and concurrent private placement. The registrant reports closing its IPO on June 20, 2025, selling 20,000,000 units at $10.00 per unit for $200,000,000 in gross proceeds, including 2,500,000 units from a partial over-allotment exercise. Simultaneously, 600,000 private placement units were sold for $6,000,000. Of the combined proceeds, $200,000,000 ($10.00 per public share) was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company. The filing establishes a 24-month completion window expiring June 20, 2027. Underwriters retained a $4,000,000 cash discount and hold an $8,000,000 deferred discount. Founder shares finalized at 6,666,667 following forfeiture. The company notes a $10,000 per month administrative services agreement with the sponsor effective June 17, 2025, and records a $2,000,000 share subscription receivable due to delayed private placement funding. Why it matters: This filing mechanically locks the redemption timeline and liquidation parameters. It fixes the per-share trust starting value at $10.00, triggers mandatory pro-rata redemption if the June 20, 2027 deadline passes, and permits up to $100,000 of trust interest to cover dissolution expenses. The notes confirm that the sponsor, officers, and directors waive redemption rights on their founder and private placement shares, pledge to vote those shares in favor of the business combination, and accept liability to restore the trust to $10.00 per share if third-party claims reduce it below that floor. The 80% fair market value acquisition test is explicitly tied to the net trust balance excluding deferred underwriting discounts and taxes. Regarding operations and strategy, the company identifies its target sector as European infrastructure but discloses it has selected no specific target and conducted no substantive discussions. Financial disclosures show total assets of $200,286,600, a working capital deficit of $843,803, and an accumulated deficit of $6,738,730, with the sponsor extending working capital advances and a promissory note to fund pre-combination activities.
What changed: SEC Form 4 insider ownership report documenting open-market common stock acquisitions by three reporting persons affiliated with the SPAC sponsor and management. According to the Form 4 filing, on 2025-06-20, three reporting persons—Axiom Intelligence Holdings 1 LLC, director Richard H. Dodd, and Director/Chief Executive Officer Douglas Edward Ward—each executed open-market purchases of 400,000 shares at $10 per share, resulting in a post-transaction holding of 400,000 shares each. The filing reports no adjustments to the public trust account, no changes to the business combination deadline, no extension filings, and no updates on merger negotiations or target selection. It contains no claims regarding customer contracts, revenue metrics, addressable market size, proprietary technology, strategic partnerships, active litigation, or executive compensation changes beyond the standard title listings. Why it matters: The disclosed trades represent secondary market activity by directors and a sponsor affiliate rather than capital deployed into the trust, warrants exercised, or forward-buyer agreements signed for a future de-SPAC transaction. Consequently, the open-market purchases do not alter per-share trust value, reduce redemption pool exposure, modify the business combination deadline, or demonstrate additional financing toward closing an announced business combination. The transactions solely reflect individual investment decisions by named insiders and provide no actionable information regarding sponsor fiduciary conduct related to deal pursuit or shareholder return mechanics.
What changed: Form 8-K Current Report documenting the consummation of Axiom Intelligence Acquisition Corp 1's initial public offering and the execution of associated corporate, underwriting, and insider agreements. The IPO closed on June 20, 2025, selling 20,000,000 units at $10.00 each for $200,000,000 in gross proceeds, including a 2,500,000-unit partial over-allotment exercise. $200,000,000 was deposited into the U.S.-based trust account. Key changes include the appointment of Dr. Claire Handby, Steven Leighton, and Christopher Ellis to the board; issuance of 6,708,333 Founder Shares to the Sponsor; sale of 600,000 private placement units for $6,000,000; and execution of a $10,000/month Administrative Services Agreement and a Letter Agreement binding insiders to vote for any proposed business combination while locking up shares for six months post-combination. Why it matters: Establishes the fully funded trust account ($200,000,000), which dictates the baseline cash available for redemption payouts or acquisition financing. Solidifies the standard 24-month completion window (approximately June 2027), setting a clear horizon for deal pursuit or liquidation. Clarifies sponsor alignment through mandatory favorable voting, share forfeiture provisions upon failed deadlines, and executive lock-ups, reducing near-term dilution and agency risk while defining the operational cost structure and governance framework ahead of target identification.
What changed: A Rule 424(b)(4) Prospectus Supplement accompanying an initial public offering registration statement for 17,500,000 units at $10.00 per unit by Axiom Intelligence Acquisition Corp 1, a Cayman Islands exempted blank check company formed to effect an initial business combination. This filing establishes a 24-month completion window from the anticipated June 20, 2025 closing date, with a stated policy to seek shareholder approvals for extensions up to 36 months, which simultaneously triggers proportional cash redemption rights for public shareholders at the pro rata trust balance. Why it matters: The document materially repositions the investment calculus by locking in severe dilution vectors, explicit timeline boundaries, and asymmetric sponsor incentives that prioritize management recovery over public shareholder returns. The 24-to-36-month redemption window anchors the exact capital-return horizon, while the $10.00 per-unit pricing and pro rata trust distribution formula replace any assumed $10.00 trust convention with precise, legally defined payout mechanics.
What changed: This document IS a routine compliance exhibit — specifically, a Form 8-A for registration of certain classes of securities pursuant to Section 12(b) of the Securities Exchange Act of 1934. It registers Units, Class A ordinary shares (par value $0.0001 per share), and Rights (each right entitling the holder to receive one-tenth (1/10) of one Class A ordinary share) for listing on The Nasdaq Stock Market LLC. Why it matters: This is a standard post-prospectus administrative step that finalizes exchange qualification without impacting the SPAC’s capital preservation mechanisms, liquidity structures, or target integration schedule. All referenced identifiers (Cayman Islands incorporation, IRS Employer Identification No. 98-1849669, principal executive offices at Berkeley Square House, 2nd Floor Berkeley Square London, United Kingdom W1J 6BD) originate exclusively from the Registrant’s self-filed submission.
What changed: A Form 3 (Statement of Beneficial Ownership by Certain Beneficial Owners and Insiders), a routine compliance exhibit filed to register or confirm the insider equity position of a reporting person at a publicly traded issuer. Per the submission dated 2025-06-17 by director Steven John Leighton, no insider equity positions were updated. The filing text explicitly states 'No non-derivative transactions or holdings reported,' indicating zero purchases, sales, conversions, or exercises of warrants, options, or restricted units. Accordingly, there is no new signal on board-level conviction, no alteration to the capitalization table, and no mechanical impact on how shares may be tendered for redemption before the 2027-06-20 deadline or on any extension voting mechanics. Why it matters: For investors tracking the $10.21 per-share trust value, sponsor conduct, or deal progress toward a business combination, this filing provides no additional data point on insider alignment, liquidity pressure, or governance shifts. The absence of reported non-derivative movements leaves the director’s tracked ownership static, eliminating near-term insider-driven supply shocks or fiduciary realignment signals. The document contains no assertions about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: This document is a Form 3, a routine compliance exhibit designated as an insider ownership report filed under Section 16(a) of the Securities Exchange Act, identifying Christoph Ackermann (Chief Operating Officer) of Axiom Intelligence Acquisition Corp 1 (AXIN) as a newly obligated reporting person. The filing confirms Ackermann’s designation as a Section 16(a) reporting person but explicitly states there are 'No non-derivative transactions or holdings reported.' Because no equity transfers, exercises, or dispositions are recorded, the operational mechanics for shareholders remain static: the trust account retains its disclosed per-share balance of $10.21, the redemption window is unadjusted, and the definitive business combination deadline remains fixed at 2027-06-20. Sponsor governance posture and extension voting parameters are unaffected by this submission. Why it matters: Investors tracking deal progress and capital preservation should note this filing serves purely as an executive registry update rather than a strategic disclosure. The report attributes no forward-looking claims, customer pipelines, revenue projections, technology roadmaps, or partnership developments to the company or its officers. Management conduct appears routine and compliant, with no signals of accelerated cash burn, altered sponsor forfeiture risk, or changed target diligence milestones. As a result, the filing does not trigger redemption pressure nor alter the trajectory toward the 2027-06-20 cutoff, though it satisfies statutory transparency requirements ahead of any eventual trust distribution or SPAC dissolution event.
What changed: SEC Form 3 – insider ownership report [0001213900-25-055348], a routine compliance exhibit filed by Director Ellis Christopher Graham for Axiom Intelligence Acquisition Corp 1 on June 17, 2025. The filing discloses zero non-derivative transactions and zero current holdings for the reporting director. There are no updated insider equity positions, no signaled lock-up expirations, and no mechanical impact on the announced deal status, the published trust value of $10.21 per share, or the structural deadline of June 20, 2027. Why it matters: For investors tracking redemption calendars, trust preservation, extensions, and sponsor conduct, this null Form 3 confirms the absence of recent directional trading by a named officer. Because the document contains no executive claims, customer disclosures, revenue metrics, market sizing, technology roadmaps, partnership agreements, litigation notices, or personnel changes, it offers no independent signal on deal progression or valuation beyond standard regulatory baselining. All attestations derive exclusively from the filing registrant and the SEC submission record.
What changed: A Form 3, Statement of Changes in Beneficial Ownership by Certain Owners of Beneficial Shares, filed by Axiom Intelligence Acquisition Corp 1’s Chief Financial Officer, Walter Robert Dilling Jr. The filing explicitly states there were no non-derivative transactions or holdings reported. This confirms no changes to insider beneficial ownership, meaning the redemption calendar, the $10.21 per-share trust account value, the 2027-06-20 business combination deadline, and deal execution remain mechanically unaltered by any insider purchase or sale activity. Why it matters: Investors monitoring redemption deadlines, trust value integrity, extension timing, deal progress, and sponsor conduct track Form 3 filings to identify pre-vote accumulation or distribution that could influence redemption surges or signal confidence levels. Per the filing, the absence of reported transactions indicates stable insider positioning and introduces no new leverage points affecting shareholder decisions or sponsor alignment. The document contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel adjustments; the sole disclosed fact is the stated lack of non-derivative transactions.
What changed: This filing is a Form 3 initial statement of beneficial ownership, functioning as a routine compliance exhibit for insider registration rather than a merger agreement, resignation, interview transcript, or investor presentation. The filing explicitly notes 'No non-derivative transactions or holdings reported,' which confirms no changes to the redemption deadline of 2027-06-20, the reported trust/share value of $10.21, extension options, deal progress, or sponsor conduct. Why it matters: The document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The sole substantive data points are the three reporting entities—Axiom Intelligence Holdings 1 LLC, Richard H. Dodd (director, 10% owner), and Douglas Edward Ward (director, CEO, 10% owner)—who attribute their baseline 10% owner status to the issuer. As an administrative registration with zero operational or financial assertions, it provides no new mechanics or fundamental indicators for investors, though its explicit transaction-free status clarifies the current ownership lock.
What changed: Form 3 — insider ownership report. Mamadou Daniel (President) disclosed no non-derivative transactions or holdings. Consequently, there are no adjustments to shareholder equity composition, trust distribution mechanics, redemption thresholds, extension voting parameters, or business combination timelines. Why it matters: Regulatory transparency requires this null filing to establish an accurate snapshot of principal insider positioning. For tracking sponsor conduct and capital alignment ahead of the combination window, the zero-transaction report confirms static holdings, eliminating near-term insider buying or selling as a factor influencing investor redemption decisions. The exhibit contains no statements on revenue, customer contracts, market positioning, technology development, strategic partnerships, ongoing litigation, or executive appointments.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.